Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Mechanism NHE1 inhibitors(Sodium/hydrogen exchanger 1 inhibitors), NHE2 inhibitors(Sodium/hydrogen exchanger 2 inhibitors), SLC9A4 blockers(solute carrier family 9 member A4 blockers) + [2] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | AT | 18 Jun 2020 |